Pulmatrix Receives US Patent for PUR0200, an Inhaled Formulation for Lung Diseases
COPD, News
Pulmatrix has received a U.S. patent for PUR0200, an inhaled formulation of tiotropium bromide for lung diseases such as chronic obstructive pulmonary disease (COPD). The company said the powder it developed does a better ... Read more